Add to ORKGOral vitamin K did not reduce bleeding in patients with excessive anticoagulation after receiving warfarin Crowther MA, Ageno W, Garcia D, et al. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med. 2009;150:293-300
Background: The efficacy and safety of vitamin K antagonists for the prevention of thromboembolism a...
Thrombosis is the process of a blood clot forming inside a blood vessel, obstructing blood flow. Ora...
To determine the best way to reverse the excessive effect of regular anticoagulation in patients wit...
Background: Low-dose oral vitamin K decreases the international normalized ratio (INR) in overantico...
BACKGROUND: Low-dose oral vitamin K decreases the international normalized ratio (INR) in overantico...
BACKGROUND: Effective use of warfarin involves keeping the international normalised ratio (INR) with...
Background: Excessive anticoagulation due to warfarin use is associated with hemorrhage. Subcutaneou...
BACKGROUND: Timely reversal of excessive anticoagulation is important in preventing bleeding complic...
Vitamin K Antagonists [VKA] are the most frequently used oral anticoagulants in clinical practice; h...
Rivaroxaban reduced stroke and systemic embolism compared with warfarin in nonvalvular AF Patel MR, ...
Patients on warfarin for mechanical heart valves are at increased risk for thromboembolic events and...
INTRODUCTION: There is currently little evidence for the optimal dosing strategy of four-factor prot...
Warfarin is the most commonly used vitamin K antagonist (VKA), based on its demonstrated efficacy in...
Warfarin, an oral vitamin K antagonist, is used to prevent arterial and venous thromboembolism in pa...
Oral anticoagulants are the most commonly used agents in the long term prophylaxis and treatment of ...
Background: The efficacy and safety of vitamin K antagonists for the prevention of thromboembolism a...
Thrombosis is the process of a blood clot forming inside a blood vessel, obstructing blood flow. Ora...
To determine the best way to reverse the excessive effect of regular anticoagulation in patients wit...
Background: Low-dose oral vitamin K decreases the international normalized ratio (INR) in overantico...
BACKGROUND: Low-dose oral vitamin K decreases the international normalized ratio (INR) in overantico...
BACKGROUND: Effective use of warfarin involves keeping the international normalised ratio (INR) with...
Background: Excessive anticoagulation due to warfarin use is associated with hemorrhage. Subcutaneou...
BACKGROUND: Timely reversal of excessive anticoagulation is important in preventing bleeding complic...
Vitamin K Antagonists [VKA] are the most frequently used oral anticoagulants in clinical practice; h...
Rivaroxaban reduced stroke and systemic embolism compared with warfarin in nonvalvular AF Patel MR, ...
Patients on warfarin for mechanical heart valves are at increased risk for thromboembolic events and...
INTRODUCTION: There is currently little evidence for the optimal dosing strategy of four-factor prot...
Warfarin is the most commonly used vitamin K antagonist (VKA), based on its demonstrated efficacy in...
Warfarin, an oral vitamin K antagonist, is used to prevent arterial and venous thromboembolism in pa...
Oral anticoagulants are the most commonly used agents in the long term prophylaxis and treatment of ...
Background: The efficacy and safety of vitamin K antagonists for the prevention of thromboembolism a...
Thrombosis is the process of a blood clot forming inside a blood vessel, obstructing blood flow. Ora...
To determine the best way to reverse the excessive effect of regular anticoagulation in patients wit...